IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0183620.html
   My bibliography  Save this article

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development

Author

Listed:
  • Morten Andersen
  • Zamra Sajid
  • Rasmus K Pedersen
  • Johanne Gudmand-Hoeyer
  • Christina Ellervik
  • Vibe Skov
  • Lasse Kjær
  • Niels Pallisgaard
  • Torben A Kruse
  • Mads Thomassen
  • Jesper Troelsen
  • Hans Carl Hasselbalch
  • Johnny T Ottesen

Abstract

The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplasms which ultimately may transform to acute myelogenous leukemia. Most recently, chronic inflammation has been described as an important factor for the development and progression of MPNs in the biological continuum from early cancer stage to the advanced myelofibrosis stage, the MPNs being described as “A Human Inflammation Model for Cancer Development“. This novel concept has been built upon clinical, experimental, genomic, immunological and not least epidemiological studies. Only a few studies have described the development of MPNs by mathematical models, and none have addressed the role of inflammation for clonal evolution and disease progression. Herein, we aim at using mathematical modelling to substantiate the concept of chronic inflammation as an important trigger and driver of MPNs.The basics of the model describe the proliferation from stem cells to mature cells including mutations of healthy stem cells to become malignant stem cells. We include a simple inflammatory coupling coping with cell death and affecting the basic model beneath. First, we describe the system without feedbacks or regulatory interactions. Next, we introduce inflammatory feedback into the system. Finally, we include other feedbacks and regulatory interactions forming the inflammatory-MPN model.Using mathematical modeling, we add further proof to the concept that chronic inflammation may be both a trigger of clonal evolution and an important driving force for MPN disease progression. Our findings support intervention at the earliest stage of cancer development to target the malignant clone and dampen concomitant inflammation.

Suggested Citation

  • Morten Andersen & Zamra Sajid & Rasmus K Pedersen & Johanne Gudmand-Hoeyer & Christina Ellervik & Vibe Skov & Lasse Kjær & Niels Pallisgaard & Torben A Kruse & Mads Thomassen & Jesper Troelsen & Hans , 2017. "Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-18, August.
  • Handle: RePEc:plo:pone00:0183620
    DOI: 10.1371/journal.pone.0183620
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183620
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183620&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0183620?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Chloé James & Valérie Ugo & Jean-Pierre Le Couédic & Judith Staerk & François Delhommeau & Catherine Lacout & Loïc Garçon & Hana Raslova & Roland Berger & Annelise Bennaceur-Griscelli & Jean Luc Ville, 2005. "A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera," Nature, Nature, vol. 434(7037), pages 1144-1148, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Rida Al-Rifai & Marie Vandestienne & Jean-Rémi Lavillegrand & Tristan Mirault & Julie Cornebise & Johanne Poisson & Ludivine Laurans & Bruno Esposito & Chloé James & Olivier Mansier & Pierre Hirsch & , 2022. "JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    2. Zijian Fang & Giuditta Corbizi Fattori & Thomas McKerrell & Rebecca H. Boucher & Aimee Jackson & Rachel S. Fletcher & Dorian Forte & Jose-Ezequiel Martin & Sonia Fox & James Roberts & Rachel Glover & , 2023. "Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    3. Remo Monti & Pia Rautenstrauch & Mahsa Ghanbari & Alva Rani James & Matthias Kirchler & Uwe Ohler & Stefan Konigorski & Christoph Lippert, 2022. "Identifying interpretable gene-biomarker associations with functionally informed kernel-based tests in 190,000 exomes," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    4. Hidehiro Itonaga & Adnan K. Mookhtiar & Sarah M. Greenblatt & Fan Liu & Concepcion Martinez & Daniel Bilbao & Masai Rains & Pierre-Jacques Hamard & Jun Sun & Afoma C. Umeano & Stephanie Duffort & Chua, 2024. "Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    5. Diana Saleiro & Jeremy Q. Wen & Ewa M. Kosciuczuk & Frank Eckerdt & Elspeth M. Beauchamp & Chidera V. Oku & Gavin T. Blyth & Mariafausta Fischietti & Liliana Ilut & Marco Colamonici & William Palivos , 2022. "Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    6. Yusuke Kimishima & Tomofumi Misaka & Tetsuro Yokokawa & Kento Wada & Koki Ueda & Koichi Sugimoto & Keiji Minakawa & Kazuhiko Nakazato & Takafumi Ishida & Motohiko Oshima & Shuhei Koide & Kotaro Shide , 2021. "Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils," Nature Communications, Nature, vol. 12(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0183620. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.